ICAD (iCAD Corp) Earnings per share growth rate in current year
iCAD, Inc. (ICAD) maintains a stable operational foundation driven by the humanitarian status of AI diagnostics and minimal geopolitical risks. However, the company faces pressure from software commoditization and intense market competition. A comparison of annual EPS growth demonstrates valuation dynamics, with the value fixed at 10.00. The business relies on the implementation of automated mammography screening in hospitals and radiology centers.
Financial and market metric breakdowns for icadmed.com (ICAD)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt burden and liquidity indicators:
- earnings and multiples data:
ICAD - Net Profit|Future Profit iCAD, Inc.|ICAD - Price to Earnings Ratio|Market Cap to Projected Earnings iCAD|ICAD - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio iCAD, Inc.|ICAD - Operating profit EBITDA|Net earnings per share for the last 12 months iCAD|ICAD - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth icadmed.com|ICAD - Earnings growth in current year|Projected earnings per share growth rate for next year iCAD, Inc.
Summary company analysis:iCAD Corp (ICAD)
iCAD, Inc. (ICAD) leadership in AI cancer diagnostics via the ProFound AI system translates directly into financial efficiency. This metric measures the percentage change in net earnings per share compared to the previous year, reflecting the real-time dynamics of monetizing its technological advantage. Analyzing the relative annual growth in earnings per share allows investors to assess the business scaling speed and the issuer's fundamental value.
Direct competitors
BeiGene Ltd. - Earnings per share increase in current year|HALO (Halozyme Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Revolution Medicines Corp RVMD|Earnings growth in current year AAPG|Expected net earnings per share growth this year cgoncology.com|Earnings growth in current year URGN (UroGen Pharma)|BCAX - Net earnings per share growth this year|Personalis Corp - Earnings growth in current year|ERAS - Earnings growth in current year|DCTH: Earnings growth in current year|Earnings per share growth this year YMAB|Net earnings per share growth this year AURA|CADL: Earnings per share increase in current year|Earnings growth in current year ARAY|Expected net earnings per share growth this year sellaslifesciences.com|Earnings per share growth in current year Actuate Therapeutics, Inc. ACTU|CTOR: Earnings per share growth this year|TuHURA - Earnings growth in current year|Protara Therapeutics Inc (TARA) - Net earnings per share growth this year|FATE (Fate Therapeutics Corp) - Net earnings per share growth this year|WHWK - Expected net earnings per share growth this year|TCRX (TScan Therapeutics Inc) - Earnings growth in current year|Champions Oncology Corp (CSBR) - Expected net earnings per share growth this year|Earnings growth in current year XBIT|Net earnings per share growth this year cel-sci.com CVM|Earnings growth in current year OSTX (OS Therapies Inc)|Earnings growth in current year radiopharmtheranostics.com RADX|Artiva - Earnings growth in current year|ANL (Adlai Nortye Ltd.) - Earnings per share growth this year|VERU: Earnings growth in current year|Net earnings per share growth this year Tempest Therapeutics Inc|XLO (Xilio Therapeutics Inc) - Earnings growth in current year|Earnings growth in current year Enochian BioSciences|Earnings per share growth in current year Mural Oncology plc (MURA)|kairospharma.com - Earnings per share growth this year|Earnings growth in current year OKUR (OnKure Therapeutics)|GDTC - Net earnings per share growth this year|Curis Corp - Earnings growth in current year|Earnings per share growth rate in current year Apollomics, Inc.|Tharimmune, Inc. (THAR) - Earnings per share growth in current year|Advanced Biomed - Earnings per share increase in current year|Net earnings per share growth this year GNPX|CLDI: Earnings per share increase in current year|Earnings growth in current year SBFM|Net earnings per share growth this year xeneticbio.com XBIO|Salarius Pharmaceuticals - Net earnings per share growth this year|Earnings growth in current year purple-biotech.com PPBT|AONC - Earnings per share growth in current year|Earnings per share increase in current year BGNE (BeiGene Ltd.)|CKPT: Earnings growth in current year|Earnings per share growth rate in current year elevationoncology.com (ELEV)|IKNA (Ikena Oncology Inc.) - Earnings growth in current year|notablelabs.com (NTBL) - Expected net earnings per share growth this year|Earnings growth in current year VIRX|Net earnings per share growth this year MorphoSys Inc MOR|Earnings growth in current year NAYA (NAYA Bio)|Earnings growth in current year Ascentage AAPGV
